NGM BIOPHARMACEUTICALS
NGM Biopharmaceuticals is a privately-held drug discovery company committed to identifying transformational medicines that dramatically improve human health. Based on emerging human clinical and genetic observations, the company has devised several innovative experimental approaches to discover new therapies for the treatment of metabolic and cardiovascular diseases. The company's current focus is on the gastrointestinal endocrine system, with an aim to identify novel factors implicated in the pathogenesis of type 2 diabetes and the apparent resolution of this grievous disease in patients who have undergone gastric bypass surgery.
NGM BIOPHARMACEUTICALS
Industry:
Biopharma Biotechnology Genetics Medical
Founded:
2007-01-01
Address:
South San Francisco, California, United States
Country:
United States
Website Url:
http://www.ngmbio.com
Total Employee:
101+
Status:
Active
Contact:
6505831646
Email Addresses:
[email protected]
Total Funding:
420.44 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Nginx
Similar Organizations
Ritter Pharmaceuticals
Ritter Pharmaceuticals discovers and commercializes treatments for gastrointestinal diseases.
ResQ Pharma
ResQ Pharma is a research & development company that develops drugs and therapies for treating lipophilic drug overdoses and poisonings.
Rockwell Medical
Rockwell Medical is a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD).
RegeneRx
RegeneRx is a biopharmaceutical company that designs, researches, and develops novel peptides targeted at diseases with unmet medical needs.
NexImmune
NexImmune is a biopharmaceutical company developing novel immuno-therapeutics based on the proprietary artificial immune technology.
NanoViricides
NanoViricides is a nano-biopharmaceutical company that develops therapeutics for patients suffering from life-threatening viral infections.
Manus Bio
Manus Bio makes nature accessible and affordable for a growing society.
MEI Pharma
MEI Pharma is a San Diego-based oncology company focused on the clinical development of novel therapies for cancer.
MiLaboratories
MiLaboratories is a biotech company developing proprietary software to profile a person's immune picture on a DNA level.
LiveLeaf
LiveLeaf develops therapeutic products designed to turn the biochemistry of plant immunity into sustainable one.
Libero Thera
Libero Thera provides drug discovery research and development services.
Latigo Biotherapeutics
Operator of a drug discovery company intended to develop novel, non-opioid therapies for chronic pain.
Lineage Cell Therapeutics
Lineage Cell Therapeutics is a clinical-stage biotechnology company developing novel cellular therapies to treat unmet medical needs.
LogicBio Therapeutics
LogicBio develops gene therapy vectors for previously incurable genetic and infectious diseases.
Axent Biosciences
Axent Biosciences is a biotech venture that engineers biomaterial technology for the development pipeline of stem cell therapy.
AQUA Therapeutics
AQUA Therapeutics primarily engages in the development of therapeutic drugs for the treatment of fibrotic diseases.
Angion
Angion Biomedica is a clinical stage organ restoration biopharmaceutical company focused on renal disease.
Avro
Avro Life Science is developing skin patches for generic drug delivery, focusing on therapeutics for children and the elderly.
Alios BioPharma
Alios BioPharma is a biotechnology company developing novel medicines for the treatment of viral diseases.
Asklepios BioPharmaceutical
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.
Genomelink
Genomelink is a platform where people discover more with their DNA data and help businesses build, market, and do research with it.
Arno Therapeutics
Arno Therapeutics is a biopharmaceutical company developing innovative products for the treatment of cancer patients.
Absci
Absci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the therapeutic potential of proteins
Artizan Biosciences
Artizan Biosciences focuses on drug discovery and development for diseases involving the human intestinal microbiota.
AlgaeCytes
AlgaeCytes uses a photobioreactor system and freshwater algal strains to produce high purity Omega 3 oils EPA.
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
Axol Bioscience
Axol Bioscience sells live human cell cultures and provides services such as genome editing to researchers.
Arbutus Biopharma
Arbutus Biopharma Corporation is a publicly-traded biopharmaceutical company.
EndoStim
EndoStim is a medical device company developing therapeutics for gastrointestinal and urological neuro-muscular disorders.
erytech
ERYtech Pharma is a biopharmaceutical company, develops enzyme-based medicinal products for the oncology, hematology and immunology sectors.
EGenesis
EGenesis focuses on leveraging genome editing technology to deliver safe and effective human transplantable cells, tissues, and organs.
Eutilex
Eutilex is a develops immunotherapy technology, anti tumor T cell therapy and antibody therapeutics, and other technology products.
BioLife Solutions
BioLife Solutions is located in Bothell, Washington, on a high-tech campus that has its roots as a dairy farm.
BioVaxys
BioVaxys is a clinical stage biotechnology company developing immunotherapeutic cancer vaccines targeting melanoma.
Frequency Therapeutics
Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue.
Totus Medicines
Totus Medicines is a provider of chemical biology technologies by creating life-changing covalent drugs.
Oxurion
Oxurion is a biotech drug development company focused on developing therapies for retinal disorders, now focusing on diabetic eye diseases.
Universal Diagnostics
UDX is an in-vitro diagnostics company developing a platform of minimally-invasive, blood-based solutions for the early detection of cancer
Kiniksa Pharmaceuticals
Kiniksa Pharmaceuticals is developing therapies for inflammatory and autoimmune conditions.
Kura Oncology
Kura Oncology, a biopharmaceutical company, advances a pipeline of precision medicines for the treatment of solid tumors and blood cancers.
KinDex Pharmaceuticals
KinDex Pharmaceuticals is a developer of novel therapeutics used to help patients suffering from metabolic disorders.
Sutro Biopharma
Sutro Biopharma develops protein therapeutics by using OCFS protein synthesis technology.
Symbiosis Pharmaceutical Services
A leading GMP contract manufacturer of novel injectable pharmaceuticals for use in clinical trials.
Scopus BioPharma
Scopus BioPharma is a biotechnology company that focused on developing therapeutics targeting serious diseases.
Seraph Biosciences
Seraph Biosciences is a developer of real-time pathogen detection systems used to treat infections.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Horizon Discovery
Horizon is a gene editing company that designs & engineers genetically-modified cells, applying them to advance human health.
Histogen
Histogen is a regenerative medicine company with a novel biological platform that replaces and regenerates tissues in the body.
Precigen
Precigen is a life sciences company researching and developing bio-therapeutic control systems to minimize toxicity.
InDex Pharmaceuticals
InDex Pharmaceuticals is a chronic disease with recurrent forest which involves a disability for several millions of down people.
Inscopix
Inscopix is pioneering a new paradigm in the quest to understand the brain and its diseases.
Igenica
Igenica is a biopharmaceutical company developing antibody-based therapeutics for the treatment of cancer.
Inventiva Pharma
Inventiva is a biopharmaceutical company with several drug candidates at clinical and preclinical stage.
Imara
Imara is provider of novel therapeutics for the people living with sickle cell disease and hemoglobinopathies.
GigaGen
GigaGen specialized in the early discovery and development of recombinant biotherapeutic medicines.
Genoa Pharmaceuticals
Genoa Pharmaceuticals develops therapies for the treatment of idiopathic pulmonary fibrosis.
Oisin Biotechnologies
Oisin Biotechnologies is a drug development company focused on mitigating the senolytic technology to combat age-related diseases.
Chamishi Therapeutics
Chamishi Therapeutics is a drug discovery and development company focused on neurodegenerative diseases and other related disorders.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Coya Therapeutics
Coya Therapeutics is a cell therapy platform company that develops first-in-class therapeutics for ALS and other neurodegenerative diseases.
Carcell Biopharma
Carcell Biopharma is a pre-clinical biotech company that promotes the development of next-generation cell and gene therapies.
CRISPR Therapeutics
CRISPR Therapeutics is focused on the development of transformative medicines using its proprietary CRISPR/Cas9 gene-editing platform.
CytRx
CytRx is a biopharmaceutical research and development company specializing in oncology.
Positive Sequence Biology
Positive Sequence Biology is a biotech company with new gene system-based editing, focused on biotech innovation & breakthrough therapies.
PolarityTE
PolarityTE is revolutionary platform induces cell and tissue polarity, creating uniquely functional tissue.
Polus
Polus is a biopharmaceutical company specializing in solutions for medical equality.
Principia Biopharma
Principia Biopharma is dedicated to bringing oral therapies to patients with significant unmet medical needs in immunology & oncology.
9 Meters Biopharma
9 Meters Biopharma is a gastrointestinal platform company focusing on patients with rare disorders and unmet needs.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Merck
Merck investment in Series E - NGM Biopharmaceuticals
Greenspring Associates
Greenspring Associates investment in Series E - NGM Biopharmaceuticals
Topspin Partners
Topspin Partners investment in Series D - NGM Biopharmaceuticals
The Column Group
The Column Group investment in Series D - NGM Biopharmaceuticals
Tichenor Ventures
Tichenor Ventures investment in Series D - NGM Biopharmaceuticals
Prospect Venture Partners
Prospect Venture Partners investment in Series D - NGM Biopharmaceuticals
Prospect Venture Partners
Prospect Venture Partners investment in Series C - NGM Biopharmaceuticals
Topspin Partners
Topspin Partners investment in Series C - NGM Biopharmaceuticals
Solon Mack Capital
Solon Mack Capital investment in Series C - NGM Biopharmaceuticals
Rho Ventures
Rho Ventures investment in Series C - NGM Biopharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-30 | NGM Bio Appoints Siobhan Nolan Mangini to President and Chief Financial Officer |
Official Site Inspections
http://www.ngmbio.com Semrush global rank: 3.96 M Semrush visits lastest month: 3.14 K
- Host name: 113.165.190.35.bc.googleusercontent.com
- IP address: 35.190.165.113
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "NGM Biopharmaceuticals"
NGM Bio
Our mission is to translate complex, powerful biology with rigor and urgency into life-changing medicines. Our vision is to make lasting scientific contributions that improve human life. Our …See details»
Our Team - NGM Bio
Sep 30, 2024 · At NGM, every team member plays a vital role in furthering our goals and advancing our mission to deliver life-changing medicines for patients. We are independent …See details»
NGM Biopharmaceuticals - Crunchbase Company …
NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system. View contacts for NGM Biopharmaceuticals to access new leads and connect with decision-makers.See details»
NGM Bio Outlines Corporate Strategy and Provides Guidance on …
NGM Bio will seek partners for the following programs: Visit www.ngmbio.com/discovery-engine/publications/to view all of NGM Bio’s posters and presentations. NGM Bio is focused …See details»
Release Details - NGM Biopharmaceuticals, Inc.
May 4, 2023 · All therapeutic candidates in the NGM Bio pipeline have been generated by its in-house discovery engine, always led by biology and motivated by unmet patient need. Today, …See details»
Release Details - NGM Biopharmaceuticals, Inc.
Jan 10, 2022 · For more information, visit https://ir.ngmbio.com/news-releases. About NGM Biopharmaceuticals, Inc. NGM Bio is focused on discovering and developing novel, life …See details»
Release Details - NGM Biopharmaceuticals, Inc.
Dec 6, 2021 · NGM is currently enrolling patients in the Phase 1/2 trial, initiated in June 2021, to evaluate the potential of NGM707 as a monotherapy and in combination with KEYTRUDA in …See details»
NGM Bio Appoints Siobhan Nolan Mangini to President and Chief …
Jun 30, 2022 · SOUTH SAN FRANCISCO, Calif., June 30, 2022 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. (NGM Bio) (Nasdaq: NGM), a biotechnology company focused on …See details»
About NGM - NGM Bio
We are a biopharmaceutical company focused on discovering and developing novel, life-changing medicines for people whose health and lives have been disrupted by disease.See details»
NGM Bio Appoints David J. Woodhouse, Ph.D. as Chief Executive …
Oct 1, 2018 · David J. Woodhouse, Ph.D. has been appointed Chief Executive Officer (CEO) and elected to NGM's Board of Directors. Aetna Wun Trombley, Ph.D. has been appointed …See details»
Merck and NGM Bio Announce Extension of Broad, Multi-Year …
NGM is a clinical stage biopharmaceutical company focused on developing novel therapeutics based on scientific understanding of key biological pathways underlying cardio-metabolic, …See details»
NGM Bio Announces $122 Million Series A Financing to Initiate ...
Jul 17, 2024 · SOUTH SAN FRANCISCO, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. (NGM Bio), a privately held biotechnology company focused on …See details»
NGM Bio Has Entered into a Definitive Agreement and Plan of …
Feb 26, 2024 · NGM Bio stockholders to receive $1.55 per share in cash, an 80% premium over the closing share price on the last trading day prior to disclosure of receipt from The Column …See details»
Discovery Engine - NGM Bio
We pursue drug discovery and development through a multi-step process geared toward translating powerful human biology into important new medicines. Our ‘secret sauce’ involves …See details»
Culture and Careers – NGM Bio
Our broad, diverse pipeline of novel, first-in-class medicines spans multiple therapeutic areas and diseases. Every program focuses on a large market indication with high unmet needs and a …See details»
VC firm that took NGM private oversees biotech’s $122M series A
Jul 17, 2024 · Three months after The Column Group acquired NGM Bio to take the biotech private, the VC firm has overseen a $122 million fundraise to fuel clinical trials of NGM’s two …See details»
Release Details - NGM Biopharmaceuticals, Inc.
Mar 11, 2024 · SOUTH SAN FRANCISCO, Calif., March 11, 2024 (GLOBE NEWSWIRE) -- NGM Biopharmaceuticals, Inc. (NGM Bio) (Nasdaq: NGM), a biotechnology company focused on …See details»
NGM Bio Announces $122 Million Series A Financing to Initiate ...
Jul 17, 2024 · NGM Biopharmaceuticals, Inc. (NGM Bio), a wholly owned subsidiary of NGM Bio Holdings, Inc., a privately held biotechnology company, is focused on discovering and …See details»
NGM Bio Announces $122 Million Series A Financing to
Jul 17, 2024 · NGM Bio will use the proceeds from the Series A financing to initiate a planned registrational trial of aldafermin, an engineered FGF19 analog, for the treatment of PSC, and …See details»
Pipeline - NGM Bio
We are currently advancing a pipeline of drug candidates, all discovered in-house, to address rare conditions with significant unmet need and cancer.See details»